Health technology assessments by Swedish TLV in Q1 of 2025

The Swedish Dental and Pharmaceutical Benefits Agency (TLV) performs national health technology assessments (with a heavy focus on health economic evaluation) as part of the “Orderly Introduction of Medical Technologies” framework or as stand-alone evaluations. 

In the first quarter of 2025, TLV released two HTAs as part of the “Orderly Introduction of Medical Technologies” in the robotic surgery field:

• ExcelsiusGPS system for robot-assisted spine surgery;
• Rosa robot-assisted system for knee surgery.

Furthermore, TLV proceeded with working on two HTAs as part of the “Orderly Introduction of Medical Technologies”:

• Assessment of advanced insulin pumps for adults with type 1 diabetes;
• MR-guided focused ultrasound (MRgFUS) in essential tremor treatment.

The full details in Swedish can be found here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.